Mankind Pharma fundamental analysis

MANKIND

2068.2

26.50 (-1.27%)
Last updated on 17 Mar, 2026 | 15:54 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Mankind Pharma Fundamentals

P/E Ratio

49.59

P/B Ratio

5.62

Div. Yield

0

Sector P/E

59.54

Sector P/B

2.65

Sec. Div. Yield

0.59

Mankind Pharma Fundamentals is currently trading with a P/E Ratio of 49.59, compared to the sector average of 59.54. Its P/B Ratio stands at 5.62, while the sector’s is 2.65. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.59%.

Mankind Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Mankind Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost